PARIN5, a Novel Thrombin Receptor Antagonist Modulates a Streptozotocin Mice Model for Diabetic Encephalopathy.

MLA

Golderman, Valery, et al. “PARIN5, a Novel Thrombin Receptor Antagonist Modulates a Streptozotocin Mice Model for Diabetic Encephalopathy.” International Journal of Molecular Sciences, vol. 24, no. 3, Feb. 2023, p. 2021. EBSCOhost, https://doi.org/10.3390/ijms24032021.

APA

Golderman, V., Goldberg, Z., Gofrit, S. G., Dori, A., Maggio, N., Chapman, J., Sher, I., Rotenstreich, Y., & Shavit-Stein, E. (2023). PARIN5, a Novel Thrombin Receptor Antagonist Modulates a Streptozotocin Mice Model for Diabetic Encephalopathy. International Journal of Molecular Sciences, 24(3), 2021. https://doi.org/10.3390/ijms24032021

Chicago

Golderman, Valery, Zehavit Goldberg, Shany Guly Gofrit, Amir Dori, Nicola Maggio, Joab Chapman, Ifat Sher, Ygal Rotenstreich, and Efrat Shavit-Stein. 2023. “PARIN5, a Novel Thrombin Receptor Antagonist Modulates a Streptozotocin Mice Model for Diabetic Encephalopathy.” International Journal of Molecular Sciences 24 (3): 2021. doi:10.3390/ijms24032021.